FDAnews Drug Daily Bulletin

Perrigo Acquires Rosemont Pharmaceuticals

Feb. 12, 2013
A A
Perrigo acquired Rosemont Pharmaceuticals for roughly $283 million in a deal that expands the brand drugmaker’s international presence and complements its UK OTC business.
MarketWatch